key: cord-0979290-xrz877h8 authors: McCall, Dr Philip; Willder, Dr Jennifer Mary; McErlane, Dr James; Shelley, Dr Ben title: Letter to the editor: A call for pragmatic bedside assessment of RV function in COVID-19 date: 2021-03-13 journal: J Cardiothorac Vasc Anesth DOI: 10.1053/j.jvca.2021.03.017 sha: e8d84e37d461a0559301b7c25139a909b9726bbe doc_id: 979290 cord_uid: xrz877h8 nan We read with interest Isgro et al's 1 recent article, describing the potential for right ventricular dysfunction (RVD) in critically ill patients with COVID-19. We agree that the combination of micro/macro thrombi, myocardial injury, sepsis with a profound systemic inflammatory response along with the combination of Acute Respiratory Distress Syndrome (ARDS) and injurious invasive ventilation, are likely to reflect a perfect storm of pathophysiology where RV dysfunction is highly likely to occur. The authors suggest that RVD is present when echocardiography parameters (including RV pulsed Doppler S'Wave velocity *S' Wave+) are "less than the lower value of the normal range." Whilst we wholeheartedly support the use of echocardiography as the cornerstone technique for assessment of RV function in this patient group, we call for a pragmatic approach which includes the combination of both qualitative and quantitative parameters 2 . The quantitative parameters described by the author have not yet been validated in this population, either to a clinical endpoint or against a reference method. In other settings, they have been shown to be inconsistent for prediction of poor RV function when compared to reference methods, and perhaps more challengingly, have been observed to vary in their predictive performance depending on the degree of RVD present 3 . Indeed, in the prospective study of 100 consecutive patients with COVID-19 presenting to hospital by Szekely et al., even in the most critically ill cohort (those receiving invasive mechanical ventilation, n=10), mean±SD values for S'Wave and TAPSE were within the normal range (10.1±3cm/s and 2.1±cm respectively) 4 . Yet in this cohort, RV dilatation (as measured by RVEDA) was a common abnormality. Where quantitative parameters are used, their combination may allow better discrimination of normal and abnormal RV function 5 . 2D-speckle tracked RV longitudinal strain has been suggested as a method to overcome some of the difficulties associated with the conventional quantitative parameters and although showing promise in research settings, has not yet found widespread use in clinical practice. During the pandemic, critical care echocardiography, delivered by clinicians at the bedside has been essential for management of critically ill patients with COVID-19. In such a setting, focussed Intensive Care Echocardiography often doesn't include the ability to measure quantitative parameters and is reliant on answering qualitative questions; is the RV dilatated or not 6 ? is there RV dysfunction or not? We have heard anecdotal reports of quantitative echocardiography (such as that offered by an accredited echocardiography service) not being available in 'red-zone' (COVID) intensive care units due to concerns regarding staff safety. We agree with Isgro et al that here is a need for large-scale prospective echocardiography data in COVID-19 patients. To this end we are conducting a multicentre prospective transthoracic echocardiographic study, to explore the incidence of RV dysfunction in critically ill patients ventilated with COVID-19 (COVID-RV) which is currently recruiting in 12 Scottish intensive care units 7 . Given the difficulties in RV assessment described, the presence of RVD for this study includes the qualitative parameters of; RV dilatation, interventricular septal flattening and a subjective description of "dysfunction." These measures have previously been demonstrated to be associated without outcome in patients with ARDS 8, 9 . The use of quantitative parameters, including speckle tracked longitudinal strain, will be explored off-line as secondary outcomes and will help provide further mechanistic insights. Isgro et al. highlight the need for prospective studies of RV protection in patients with COVID-19. We applaud this aim, and like them, we believe such an approach could lead to meaningful patient benefit. We urge however, that any research informing such a study, or indeed when describing appropriate inclusion criteria for a trial, should include an echocardiographic definition of RVD that is sufficiently pragmatic to empower the bedside clinician to make the diagnosis. South Eastern Health and Social Care Trust The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography Right ventricular systolic function assessment: rank of echocardiographic methods vs. cardiac magnetic resonance imaging Spectrum of Cardiac Manifestations in COVID-19 The utility of transthoracic echocardiographic measures of right ventricular systolic function in a lung resection cohort. 6:7, 2019. 6. Intensive Care Society: Focused Ultrasound for Intensive Care Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19 Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome